CSPC Pharmaceutical Group Limited

CSPCY · OTC
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income$2,792$1,391$3,019$7,389
Dep. & Amort.$758$753$631$631
Deferred Tax$0$0$0$0
Stock-Based Comp.-$79$98$118$138
Change in WC$0-$206$0-$3,661
Other Non-Cash-$3,015$1,272-$2,344-$1,315
Operating Cash Flow$456$3,308$1,425$3,145
Investing Activities
PP&E Inv.-$1,318-$2,123-$649-$887
Net Acquisitions$0-$163$0-$16
Inv. Purchases$0-$2,414$0-$401
Inv. Sales/Matur.$0$0$0$648
Other Inv. Act.$1,001$2,520-$1,484$392
Investing Cash Flow-$318-$2,181-$2,132-$263
Financing Activities
Debt Repay.-$57$30-$86$0
Stock Issued$0$0$0-$61
Stock Repurch.-$38$353-$379-$244
Dividends Paid$0-$1,848-$1,531-$1,584
Other Fin. Act.$74$624-$291$201
Financing Cash Flow-$21-$3,155-$2,288-$1,383
Forex Effect$122-$1$1-$1
Net Chg. in Cash$239-$7,492$8,054$1,555
Supplemental Information
Beg. Cash$818$7,492$0$8,929
End Cash$1,057$0$7,492$10,484
Free Cash Flow$290-$776$776$1,957
CSPC Pharmaceutical Group Limited (CSPCY) Financial Statements & Key Stats | AlphaPilot